Pirisudanol: Difference between revisions

Jump to navigation Jump to search
Newer edit →
VisualWikitext
Turky Alkathery (talk | contribs)
CMEUser, nocaptcha, Administrators
6,562 edits
No edit summary
 
Turky Alkathery (talk | contribs)
CMEUser, nocaptcha, Administrators
6,562 edits
No edit summary
Line 39: Line 39:
| StdInChIKey      = KTOAWCPDBUCJED-UHFFFAOYSA-N
| StdInChIKey      = KTOAWCPDBUCJED-UHFFFAOYSA-N
}}
}}
              __NOTOC__
{{SI}}
{{CMG}}


==Overview==
   
'''Pirisudanol''' ('''Mentis''', '''Menthen''', '''Mentium''', '''Nadex''', '''Nadexen''', '''Nadexon''', '''Pridana''', '''Stivane'''), also known as '''pyrisuccideanol''', is the [[succinic acid]] [[ester]] of [[pyridoxine]] (a form of [[vitamin B6|vitamin B<sub>6</sub>]]) and of [[deanol]] (DMAE).<ref name="urlPsycho-Babble Medication Thread 69493">{{cite web | url = +http://www.dr-bob.org/cgi-bin/pb/mget.pl?post=/babble/20010708/msgs/69493.html#69493 | title = Psycho-Babble Medication Thread 69493 | format = | work = | accessdate = }}</ref> It has been used in [[Europe]] in the treatment of mild [[cognitive impairment]] as well as [[Fatigue (medical)|fatigue]] and [[major depression|depression]].<ref name="urlPsycho-Babble Medication Thread 69493">{{cite web | url = +http://www.dr-bob.org/cgi-bin/pb/mget.pl?post=/babble/20010708/msgs/69493.html#69493 | title = Psycho-Babble Medication Thread 69493 | format = | work = | accessdate = }}</ref><ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of Pharmacological Agents | publisher = Chapman & Hall/CRC | location = Boca Raton | year = 1996 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = http://books.google.com/books?id=A0THacd46ZsC&lpg=PA1626&dq=Pirisudanol&as_brr=3&pg=PA1626#v=onepage&q=&f=false}}</ref><ref name="pmid1261486">{{cite journal | author = Bathien N, Willer JC, Hugelin A | title = [Effect of psychotropic drugs on physiological variations and psychometric scores during attention] | language = French | journal = L'Encéphale | volume = 2 | issue = 1 | pages = 55–60 | year = 1976 | pmid = 1261486 | doi = | url = }}</ref><ref name="pmid7297757">{{cite journal | author = Murphy JE | title = An evaluation of pyrisuccideanol maleate (Nadex) in the treatment of mild to moderate depression in patients aged 55 years and over, presenting in general practice | journal = The Journal of International Medical Research | volume = 9 | issue = 5 | pages = 330–7 | year = 1981 | pmid = 7297757 | doi = | url = }}</ref><ref name="pmid6138876">{{cite journal | author = Zmorski T | title = [Experience with Nadex in an ambulatory psychiatric practice] | language = German | journal = Therapeutische Umschau. Revue Thérapeutique | volume = 40 | issue = 9 | pages = 817–20 |date=September 1983 | pmid = 6138876 | doi = | url = }}</ref>
'''Pirisudanol''' ('''Mentis''', '''Menthen''', '''Mentium''', '''Nadex''', '''Nadexen''', '''Nadexon''', '''Pridana''', '''Stivane'''), also known as '''pyrisuccideanol''', is the [[succinic acid]] [[ester]] of [[pyridoxine]] (a form of [[vitamin B6|vitamin B<sub>6</sub>]]) and of [[deanol]] (DMAE).<ref name="urlPsycho-Babble Medication Thread 69493">{{cite web | url = +http://www.dr-bob.org/cgi-bin/pb/mget.pl?post=/babble/20010708/msgs/69493.html#69493 | title = Psycho-Babble Medication Thread 69493 | format = | work = | accessdate = }}</ref> It has been used in [[Europe]] in the treatment of mild [[cognitive impairment]] as well as [[Fatigue (medical)|fatigue]] and [[major depression|depression]].<ref name="urlPsycho-Babble Medication Thread 69493">{{cite web | url = +http://www.dr-bob.org/cgi-bin/pb/mget.pl?post=/babble/20010708/msgs/69493.html#69493 | title = Psycho-Babble Medication Thread 69493 | format = | work = | accessdate = }}</ref><ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of Pharmacological Agents | publisher = Chapman & Hall/CRC | location = Boca Raton | year = 1996 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = http://books.google.com/books?id=A0THacd46ZsC&lpg=PA1626&dq=Pirisudanol&as_brr=3&pg=PA1626#v=onepage&q=&f=false}}</ref><ref name="pmid1261486">{{cite journal | author = Bathien N, Willer JC, Hugelin A | title = [Effect of psychotropic drugs on physiological variations and psychometric scores during attention] | language = French | journal = L'Encéphale | volume = 2 | issue = 1 | pages = 55–60 | year = 1976 | pmid = 1261486 | doi = | url = }}</ref><ref name="pmid7297757">{{cite journal | author = Murphy JE | title = An evaluation of pyrisuccideanol maleate (Nadex) in the treatment of mild to moderate depression in patients aged 55 years and over, presenting in general practice | journal = The Journal of International Medical Research | volume = 9 | issue = 5 | pages = 330–7 | year = 1981 | pmid = 7297757 | doi = | url = }}</ref><ref name="pmid6138876">{{cite journal | author = Zmorski T | title = [Experience with Nadex in an ambulatory psychiatric practice] | language = German | journal = Therapeutische Umschau. Revue Thérapeutique | volume = 40 | issue = 9 | pages = 817–20 |date=September 1983 | pmid = 6138876 | doi = | url = }}</ref>


Line 51: Line 56:
{{Nootropics}}
{{Nootropics}}
{{Antidepressants}}
{{Antidepressants}}
{{Cholinergics}}


[[Category:Pyridines]]
[[Category:Pyridines]]
[[Category:Phenols]]
[[Category:Phenols]]
[[Category:Alcohols]]
[[Category:Alcohols]]
[[Category:Succinates]]
[[Category:Drug]]
[[Category:Prodrugs]]
[[Category:Prodrugs]]
[[Category:Nootropics]]
[[Category:Nootropics]]
[[Category:Antidepressants]]
[[Category:Antidepressants]]
{{nervous-system-drug-stub}}

Revision as of 15:54, 12 April 2015

Pirisudanol
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration		Oral
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC16H24N2O6
Molar mass340.372 g/mol
3D model (JSmol)
  (verify)

WikiDoc Resources for Pirisudanol

Articles

Most recent articles on Pirisudanol

Most cited articles on Pirisudanol

Review articles on Pirisudanol

Articles on Pirisudanol in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pirisudanol

Images of Pirisudanol

Photos of Pirisudanol

Podcasts & MP3s on Pirisudanol

Videos on Pirisudanol

Evidence Based Medicine

Cochrane Collaboration on Pirisudanol

Bandolier on Pirisudanol

TRIP on Pirisudanol

Clinical Trials

Ongoing Trials on Pirisudanol at Clinical Trials.gov

Trial results on Pirisudanol

Clinical Trials on Pirisudanol at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pirisudanol

NICE Guidance on Pirisudanol

NHS PRODIGY Guidance

FDA on Pirisudanol

CDC on Pirisudanol

Books

Books on Pirisudanol

News

Pirisudanol in the news

Be alerted to news on Pirisudanol

News trends on Pirisudanol

Commentary

Blogs on Pirisudanol

Definitions

Definitions of Pirisudanol

Patient Resources / Community

Patient resources on Pirisudanol

Discussion groups on Pirisudanol

Patient Handouts on Pirisudanol

Directions to Hospitals Treating Pirisudanol

Risk calculators and risk factors for Pirisudanol

Healthcare Provider Resources

Symptoms of Pirisudanol

Causes & Risk Factors for Pirisudanol

Diagnostic studies for Pirisudanol

Treatment of Pirisudanol

Continuing Medical Education (CME)

CME Programs on Pirisudanol

International

Pirisudanol en Espanol

Pirisudanol en Francais

Business

Pirisudanol in the Marketplace

Patents on Pirisudanol

Experimental / Informatics

List of terms related to Pirisudanol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pirisudanol (Mentis, Menthen, Mentium, Nadex, Nadexen, Nadexon, Pridana, Stivane), also known as pyrisuccideanol, is the succinic acid ester of pyridoxine (a form of vitamin B6) and of deanol (DMAE).[1] It has been used in Europe in the treatment of mild cognitive impairment as well as fatigue and depression.[1][2][3][4][5]

See also

References

  1. ↑ 1.0 1.1 [+http://www.dr-bob.org/cgi-bin/pb/mget.pl?post=/babble/20010708/msgs/69493.html#69493 "Psycho-Babble Medication Thread 69493"] Check |url= value (help).
  2. ↑ David J. Triggle (1996). Dictionary of Pharmacological Agents. Boca Raton: Chapman & Hall/CRC. ISBN 0-412-46630-9.
  3. ↑ Bathien N, Willer JC, Hugelin A (1976). "[Effect of psychotropic drugs on physiological variations and psychometric scores during attention]". L'Encéphale (in French). 2 (1): 55–60. PMID 1261486.
  4. ↑ Murphy JE (1981). "An evaluation of pyrisuccideanol maleate (Nadex) in the treatment of mild to moderate depression in patients aged 55 years and over, presenting in general practice". The Journal of International Medical Research. 9 (5): 330–7. PMID 7297757.
  5. ↑ Zmorski T (September 1983). "[Experience with Nadex in an ambulatory psychiatric practice]". Therapeutische Umschau. Revue Thérapeutique (in German). 40 (9): 817–20. PMID 6138876.


Template:Nootropics Template:Antidepressants

Retrieved from "https://www.wikidoc.org/index.php?title=Pirisudanol&oldid=1086306"